Journals / Turkish Journal of Family Medicine and Primary Care / 2018 / Cilt: 12 - Sayı: 1

An Allergic Reaction in the Treatment of Bupropion Hcl: A Case Report

Bupropion Hcl Tedavisinde Gelişen Alerjik Reaksiyon: Olgu Sunumu

Pages
68–71
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, it is aimed to emphasize how important it is to get a simple history and physical examination in terms of our patients in our health services.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Smoking leads to cardiovascular diseases, cancers, and respiratory tract diseases.
📊
Key Findings & Data:The most common side effect is; mouth dryness, insomnia, sleep divisions, roseola, and itching, and the risk of allergic reactions is 1 / 1000-10000.
💡
Conclusion & Impact:In this article, it is aimed to emphasize how important it is to get a simple history and physical examination in terms of our patients in our health services.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Sigara bırakma · bupropion · alerjik reaksiyon

Abstract

Smoking leads to cardiovascular diseases, cancers, and respiratory tract diseases. Also, smoking is at the center of the causes of preventable death and disability. Bupropion HCL is an antidepressant and reduces the likelihood of smoking and the intensity of withdrawal complaints. The most common side effect is; mouth dryness, insomnia, sleep divisions, roseola, and itching, and the risk of allergic reactions is 1 / 1000-10000. In patients treated with bupropion HCL, the most common side effect causing treatment discontinuation was reported as tremor and rash. In this article, it is aimed to emphasize how important it is to get a simple history and physical examination in terms of our patients in our health services.

Özet

Sigara kullanımı, kalp ve damar hastalıkları, kanserler ve solunum yolu hastalıklarına yol açan, önlenebilir ölüm ve sakatlık nedenlerinin başında yer almaktadır. Bupropion HCL bir antidepresan olup sigara içme isteğini ve yoksunluk yakınmalarının şiddetini azaltmaktadır. En yaygın yan etkisi; ağız kuruluğu, uykusuzluk, uyku bölünmeleri, deride kızarıklık ve kaşıntı olup alerjik reaksiyon riski 1/1000-10000'dir. Sigara bırakmada Bupropion HCL ile tedavi olan hastaların tedaviyi yarım bırakma nedenlerinden en sık olumsuz etki tremor ve döküntü olarak bildirilmiştir. Bu makalemizde, hastalarımıza verdiğimiz sağlık hizmetlerinde basit öykü alma ve fizik muayenenin hastalarımız açısından ne kadar önemli olduğu vurgulanmak istenmiştir.

🔖

Cite This Article

GÜCÜK, S. (2018). An Allergic Reaction in the Treatment of Bupropion Hcl: A Case Report. Turkish Journal of Family Medicine and Primary Care, Cilt: 12 - Sayı: 1, 68–71. https://ajindex.com/articles/371361

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Holm KJ, Spencer CM. Bupropion: A review of its use in the management of smoking cessation. Drugs 2000; 59(4): 1007-24
  2. I.Campbell. Nicotine replacement therapy in smoking cessation. Thorax 2003; 58(6): 464-65
  3. Dale LC, Ebbert JO, Hays JT, Hurt RD. Treatment of nicotine dependence. Mayo Clin Proc 2000;75(12):1311-16
  4. Roddy E. Bupropion and other non nicotine pharmacotherapies. BMJ 2004; 28;328(7438):509-11
  5. Rennard SI, Daughton DM. Smoking cessation. Chest 2000; 117(5 Suppl 2):360S-64S
  6. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000; 55(12): 987-99
  7. Kotz D. Implementation of a new 'opt-out' default for tobacco treatment is urgently needed, but requires free access to evidence-based treatments. Addiction 2015;110(3):387-88
  8. Yorgancıoğlı A, Esen A. Sigara bağımlılığı ve hekimler. Toraks Dergisi 2000;1:90-95
  9. Faseru B, Turner M, Casey G, Ruder C, Befort CA, Ellerbeck EF, et al. Evaluation of a hospital-based tobacco treatment service: outcomes and lessons learned. J Hosp Med. 2011;6(4):211-8
  10. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146. doi: 10.1002/14651858.CD000146.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD000146
  11. Ferry LH. Non-nicotine pharmacotherapy for smoking cessation. Prim Care. 1999;26(3):653-69
  12. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation.N Engl J Med. 1997 23;337(17):1195-202
  13. Kutlu R, Karademirci MM, KT. Sigara bırakma tedavisi sırasında Bupropion Hcl’e bağlı gelişen Serum Hastalığı benzeri reaksiyon: Olgu Sunumu. Türk Aile Hek Derg 2017; 21 (1): 44-48
  14. Polat M, Uzun Ö, Örs I, Boran Ç. Pityriasis rosea-like drug eruption due to bupropion: a case report. Hum Exp Toxicol 2014:33(12):1294-1296
  15. Erdem R, Rahman, S, Avcı L, Demirel B, Köseoğlu S, Fırat G ve ark. Hasta memnuniyetinin hasta bağlılığı üzerine etkisi. Erciyes Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi 2008;31:95-110.